Opus Genetics, Inc.
IRD
$4.03
-$0.03-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.16M | 3.87M | 3.08M | 2.88M | 4.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16M | 3.87M | 3.08M | 2.88M | 4.37M |
| Cost of Revenue | 10.48M | 10.43M | 6.41M | 6.02M | 7.85M |
| Gross Profit | -8.32M | -6.56M | -3.33M | -3.14M | -3.48M |
| SG&A Expenses | 6.04M | 4.89M | 4.98M | 5.77M | 6.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.52M | 15.32M | 11.39M | 11.79M | 14.30M |
| Operating Income | -14.36M | -11.45M | -8.31M | -8.91M | -9.93M |
| Income Before Tax | -65.54M | -16.52M | -17.45M | -7.42M | -8.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.54M | -16.52M | -17.45M | -7.42M | -8.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.54M | -16.52M | -17.45M | -7.42M | -8.19M |
| EBIT | -14.36M | -11.45M | -8.31M | -8.91M | -9.93M |
| EBITDA | -14.35M | -11.44M | -8.30M | -8.89M | -9.92M |
| EPS Basic | -0.75 | -0.21 | -0.25 | -0.12 | -0.24 |
| Normalized Basic EPS | -0.47 | -0.13 | -0.15 | -0.07 | -0.15 |
| EPS Diluted | -0.75 | -0.21 | -0.25 | -0.12 | -0.24 |
| Normalized Diluted EPS | -0.47 | -0.13 | -0.15 | -0.07 | -0.15 |
| Average Basic Shares Outstanding | 86.89M | 80.59M | 70.64M | 63.38M | 33.88M |
| Average Diluted Shares Outstanding | 86.89M | 80.59M | 70.64M | 63.38M | 33.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |